标题
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
作者
关键词
Psoriasis, IL-17A, IL-17F, IL-17 receptor A, Innate immunity, Adaptive immunity
出版物
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-15
DOI
10.1007/s12016-018-8702-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cytokine production by human neutrophils: Revisiting the “dark side of the moon”
- (2018) Nicola Tamassia et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT-3–independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection
- (2018) Anthony J. St. Leger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A
- (2018) Yumeng Li et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In response to Lebwohl et al, “Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials”
- (2018) Evan A. Rieder JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It
- (2018) Nicola Tamassia et al. Frontiers in Immunology
- Sexy again: the renaissance of neutrophils in psoriasis
- (2017) Michael P. Schön et al. EXPERIMENTAL DERMATOLOGY
- The role of IL 23 in the treatment of psoriasis
- (2017) Lluís Puig Expert Review of Clinical Immunology
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones
- (2017) Tiago R. Matos et al. JOURNAL OF CLINICAL INVESTIGATION
- Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model
- (2017) Azumi Ueyama et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
- (2017) Megan Hohenberger et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- 699 Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution to immune-mediated inflammatory skin response
- (2017) A. Maroof et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials
- (2017) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis
- (2017) G. Girolomoni et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Clinician’s Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis
- (2016) April W. Armstrong et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Response to: ‘Let's not fool ourselves. In RA, the ACR/EULAR remission criteria are not perfect!’ by Baker et al
- (2016) Maarten Boers ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients
- (2016) G. Guggino et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
- (2016) Andrea Chiricozzi et al. Expert Opinion On Drug Safety
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes
- (2016) Ryuta Muromoto et al. INTERNATIONAL IMMUNOLOGY
- Human mast cells capture, store, and release bioactive, exogenous IL-17A
- (2016) Troy Noordenbos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
- (2016) Peter C.M. van de Kerkhof et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
- (2016) Ajay Nirula et al. RHEUMATOLOGY
- Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris
- (2015) A. Chiricozzi et al. BRITISH JOURNAL OF DERMATOLOGY
- Dermal γδ T cells – What have we learned?
- (2015) Rebecca L. O’Brien et al. CELLULAR IMMUNOLOGY
- New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
- (2015) Anthony A. Gaspari et al. Dermatologic Therapy
- Dermal IL-17-producing γδ T cells establish long-lived memory in the skin
- (2015) Tom Hartwig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
- (2015) Kristian Reich et al. EXPERIMENTAL DERMATOLOGY
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
- (2015) Shunya Mashiko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An autoimmune “attack” on melanocytes triggers psoriasis and cellular hyperplasia
- (2015) James G. Krueger JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies
- (2015) Andrew Blauvelt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Harnessing the Therapeutic Potential of Th17 Cells
- (2015) Jonas Bystrom et al. MEDIATORS OF INFLAMMATION
- Genetic and epigenetic basis of psoriasis pathogenesis
- (2015) Aditi Chandra et al. MOLECULAR IMMUNOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Basic biology and role of interleukin-17 in immunity and inflammation
- (2015) Camille Zenobia et al. PERIODONTOLOGY 2000
- Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis
- (2015) Darren D. O’Rielly et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
- (2015) Jennifer Belasco et al. Arthritis & Rheumatology
- Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid
- (2015) Emmerik F. A. Leijten et al. Arthritis & Rheumatology
- Current Concepts in Psoriatic Arthritis: Pathogenesis and Management
- (2014) K Vlam et al. ACTA DERMATO-VENEREOLOGICA
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
- (2014) Susanne Karbach et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The IL-23/IL-17 axis in psoriatic arthritis
- (2014) Erika Suzuki et al. AUTOIMMUNITY REVIEWS
- Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling
- (2014) A. Johnston et al. BRITISH JOURNAL OF DERMATOLOGY
- Cellular sources of IL-17 in psoriasis: a paradigm shift?
- (2014) Romy R. M. C. Keijsers et al. EXPERIMENTAL DERMATOLOGY
- A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry
- (2014) Francesca Tamarozzi et al. IMMUNOLOGY LETTERS
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
- (2014) C. B. Russell et al. JOURNAL OF IMMUNOLOGY
- IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis
- (2014) Christian Erbel et al. JOURNAL OF IMMUNOLOGY
- A New Player on the Psoriasis Block: IL-17A- and IL-22-Producing Innate Lymphoid Cells
- (2014) Nicole L. Ward et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood
- (2014) Claire Q.F. Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
- (2014) Andrea Chiricozzi et al. PLoS One
- Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease
- (2014) Xiao-Rong Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
- (2014) Lisa GM van Baarsen et al. ARTHRITIS RESEARCH & THERAPY
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin
- (2013) B. Dyring-Andersen et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer
- (2013) Lequn Li et al. CLINICAL IMMUNOLOGY
- IL-17 targeted therapies for psoriasis
- (2013) Andrea Chiricozzi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
- (2013) Bruce W. Kirkham et al. IMMUNOLOGY
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Dermal Clusters of Mature Dendritic Cells and T Cells Are Associated with the CCL20/CCR6 Chemokine System in Chronic Psoriasis
- (2013) Tae-Gyun Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17
- (2013) Romy R.M.C Keijsers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2
- (2013) Patricia R Taylor et al. NATURE IMMUNOLOGY
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- Innate Lymphoid Cells: Balancing Immunity, Inflammation, and Tissue Repair in the Intestine
- (2012) Elia D. Tait Wojno et al. Cell Host & Microbe
- Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
- (2012) Tabassome Simon et al. EUROPEAN HEART JOURNAL
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCR6 Is Required for Epidermal Trafficking of γδ-T Cells in an IL-23-Induced Model of Psoriasiform Dermatitis
- (2012) Tomotaka Mabuchi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
- (2012) DirkJan Hijnen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs
- (2012) Leanne M. Johnson-Huang et al. PLoS One
- Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?
- (2012) Rik J. Lories et al. Current Rheumatology Reports
- TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
- (2012) Ashish K. Marwaha et al. Frontiers in Immunology
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Recent advances in the IL-17 cytokine family
- (2011) Sarah L Gaffen CURRENT OPINION IN IMMUNOLOGY
- Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
- (2011) Anne Dudeck et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
- (2011) Seon Hee Chang et al. IMMUNITY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Epidermal CCR6 + γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis
- (2011) Tomotaka Mabuchi et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Gone but Not Forgotten: Lesional Memory in Psoriatic Skin
- (2011) Rachael A. Clark JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CCR6 as a possible therapeutic target in psoriasis
- (2010) Michael N Hedrick et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resolved Psoriasis Lesions Retain Expression of a Subset of Disease-Related Genes
- (2010) Mayte Suárez-Fariñas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
- (2009) Michael N. Hedrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques
- (2009) Onno J de Boer et al. JOURNAL OF PATHOLOGY
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now